Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vistagen Therapeutics (VTGN) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Vistagen Therapeutics (VTGN) over the last 3 years, with Q4 2025 value amounting to $647000.0.

  • Vistagen Therapeutics' Interest & Investment Income fell 3724.54% to $647000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 million, marking a year-over-year decrease of 4563.01%. This contributed to the annual value of $4.6 million for FY2025, which is 3598.93% up from last year.
  • According to the latest figures from Q4 2025, Vistagen Therapeutics' Interest & Investment Income is $647000.0, which was down 3724.54% from $630000.0 recorded in Q3 2025.
  • Over the past 5 years, Vistagen Therapeutics' Interest & Investment Income peaked at $1.5 million during Q4 2023, and registered a low of $98000.0 during Q2 2023.
  • Moreover, its 3-year median value for Interest & Investment Income was $855000.0 (2025), whereas its average is $899636.4.
  • Per our database at Business Quant, Vistagen Therapeutics' Interest & Investment Income surged by 132653.06% in 2024 and then plummeted by 5051.06% in 2025.
  • Quarter analysis of 3 years shows Vistagen Therapeutics' Interest & Investment Income stood at $1.5 million in 2023, then plummeted by 32.79% to $1.0 million in 2024, then plummeted by 37.25% to $647000.0 in 2025.
  • Its Interest & Investment Income was $647000.0 in Q4 2025, compared to $630000.0 in Q3 2025 and $711000.0 in Q2 2025.